We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Government response to the ACMD review of the evidence on the use and harms of diphenidine.
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of diphenidine and other related substances.
When entering the UK, you need to prove your medicine is prescribed to you if it contains a controlled drug - find out what proof you need to get.
A summary of letters and drug alerts recently sent to healthcare professionals.
Severe infusion-related hypersensitivity reactions have occurred in patients receiving temsirolimus.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.